Please ensure Javascript is enabled for purposes of website accessibility Continuous Gluscose Monitoring Device - Pre Market Asset Sale | Tony Sansone | Transworld Business Advisors

Continuous Gluscose Monitoring Device - Pre Market Asset Sale

Listing Number: 2401-715627


Wearable Glucose Sensor - Continuous Glucose Monitor. Company founded in 2013. About $10M invested. Patent pending technology intends to provide highest value and accuracy with lowest sensor drift. It is the foundational technology for the artificial pancreas. With 23.1 million diagnosed and an estimated 7.2 million undiagnosed diabetics in the US and 422 million worldwide (WHO, 2014), continuous, prick free monitoring will offer patients and their doctors painless affordable continuous data to monitor and even potentially reverse the disease in pre-diabetic and Type II diabetics. 1st round of clinical trials have been completed following patent filing and extensive research but it's not past risk threshold yet. Continuous Gluscose Monitoring adoption currently represents about 7% of the market but it is expected to grow to perhaps 34% by 2026 with an affordable alternative. Research and Development is based in So, CA and the next trial is planned for October 2021 to collect data to validate accuracy. Down payment $5,000,000 with balance dependent upon structure.

Listing Details

  • Price: $5,000,000
  • Down Payment: $5,000,000
  • Sellers Discretionary Earnings: $0
  • Total Sales: $0
  • Location: San Diego County, California

  • Inventory: $0
  • FF&E: $0
  • Employees:
  • Year Established: 2013
  • Reason for Selling: Needs home with industry appropirate buyer who can infuse capital
  • Category: Medical Related Biz
Continuous Gluscose Monitoring Device - Pre Market Asset Sale

Contact Agent:

Tony Sansone
Want to save this listing? Sign Up Now